Senior insider sale
Chief Commercial Officer at IRONWOOD PHARMACEUTICALS INC — senior position signals high conviction
$839.9K
182.19K shares
MCCOURT THOMAS A plans to sell 182.19K shares of IRONWOOD PHARMACEUTICALS INC valued at approximately $839.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements
N/A
Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements
N/A
Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements
N/A
Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/20/2025 | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements N/A | 180K | — |
3/5/2024 | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements N/A | 88.29K | — |
3/8/2023 | Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements N/A | 80.20K | — |
3/8/2022 | Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements N/A | 62.22K | — |
| Total | 410.71K | ||
Units to sell
182.19K
Market value
$839.9K
Units
182.19K
Value
$839.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/23/2026 | 182.19K | $839.9K | Nasdaq | Planned |
| Total | 182.19K | $839.9K | ||